Jyong Biotech Ltd. (MENS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Jyong Biotech Ltd. (MENS) closed at USD 2.05 on 2026-10-14, a change of -94.9 % over the past year, with a market capitalization of USD 150.53M.

Jyong Biotech Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Jyong Biotech Ltd. key figures

Previous close

USD 2.05 (2026-10-14)

1-year change

-94.9 %

Market cap

USD 150.53M

Enterprise value

USD 164.36M

P/E ratio (trailing)

-33.00

P/E ratio (forward)

n/a

EPS (trailing)

-0.06

EPS (forward)

n/a

PEG ratio

n/a

Price to book

-5.89

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

4.35

Employees

27

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Jyong Biotech Ltd.

Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Jyong Biotech Ltd. and compare it with other stocks.